Compile Data Set for Download or QSAR
Found 94 with Last Name = 'kawashima' and Initial = 'k'
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM414420((R)-7-[4-(2-ethoxycarbonyl-2-hydroxyethyl)oxy-2-me...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331838((R)-7-[4-(2-ethoxycarbonyl-2-hydroxyethyl)oxy-2-me...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527568(US11186588, Example 26)copy SMILES
Affinity DataIC50: 12.3nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331841((S)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331841((S)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331840((R)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331840((R)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331839((S)-7-[4-(2,4-dihydroxybutyl)oxy-2-methoxyphenyl]-...)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331839((S)-7-[4-(2,4-dihydroxybutyl)oxy-2-methoxyphenyl]-...)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527554(US11186588, Example 9)copy SMILES
Affinity DataIC50: 17.6nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527550(US11186588, Example 5)copy SMILES
Affinity DataIC50: 27.5nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527563(US11186588, Example 21 | US11186588, Example 22)copy SMILES
Affinity DataIC50: 30.3nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527557(US11186588, Example 12)copy SMILES
Affinity DataIC50: 32.1nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331836((S)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...)copy SMILEScopy InChI
Affinity DataIC50: 33nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331836((S)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...)copy SMILEScopy InChI
Affinity DataIC50: 33nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527563(US11186588, Example 21 | US11186588, Example 22)copy SMILES
Affinity DataIC50: 33.6nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331837((R)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...)copy SMILEScopy InChI
Affinity DataIC50: 34nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331837((R)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...)copy SMILEScopy InChI
Affinity DataIC50: 34nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527616(US11186588, Example 92)copy SMILES
Affinity DataIC50: 34.2nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527608(US11186588, Example 81)copy SMILES
Affinity DataIC50: 47.2nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527567(US11186588, Example 25)copy SMILES
Affinity DataIC50: 50.3nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527549(US11186588, Example 3)copy SMILES
Affinity DataIC50: 51.9nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527560(US11186588, Example 16)copy SMILES
Affinity DataIC50: 77.5nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331842(7-[4-(3-t-butoxycarbonyl-2-hydroxypropyl)oxy-2-met...)copy SMILEScopy InChI
Affinity DataIC50: 83nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331842(7-[4-(3-t-butoxycarbonyl-2-hydroxypropyl)oxy-2-met...)copy SMILEScopy InChI
Affinity DataIC50: 83nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527551(US11186588, Example 6)copy SMILES
Affinity DataIC50: 86.4nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527572(US11186588, Example 33)copy SMILES
Affinity DataIC50: 87.2nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331844(8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxy-2-...)copy SMILEScopy InChI
Affinity DataIC50: 93nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331844(8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxy-2-...)copy SMILEScopy InChI
Affinity DataIC50: 93nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527610(US11186588, Example 83 | US11186588, Example 86)copy SMILES
Affinity DataIC50: 95.3nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527617(N-(4-(2,3,9-trimethyl-6H-thieno[2,3-e][1,2,4]triaz...)copy SMILES
Affinity DataIC50: 96nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527553(US11186588, Example 8)copy SMILES
Affinity DataIC50: 104nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527575(US11186588, Example 38)copy SMILES
Affinity DataIC50: 106nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331843(8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxymet...)copy SMILEScopy InChI
Affinity DataIC50: 123nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331843(8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxymet...)copy SMILEScopy InChI
Affinity DataIC50: 123nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527609(US11186588, Example 82)copy SMILES
Affinity DataIC50: 135nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527561(US11186588, Example 18)copy SMILES
Affinity DataIC50: 144nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527571(US11186588, Example 31)copy SMILES
Affinity DataIC50: 150nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527565(US11186588, Example 23)copy SMILES
Affinity DataIC50: 158nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527555(US11186588, Example 10)copy SMILES
Affinity DataIC50: 192nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527585(US11186588, Example 49)copy SMILES
Affinity DataIC50: 197nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527558(US11186588, Example 13)copy SMILES
Affinity DataIC50: 233nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527601(US11186588, Example 73)copy SMILES
Affinity DataIC50: 246nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527587(US11186588, Example 51)copy SMILES
Affinity DataIC50: 265nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527570(US11186588, Example 29)copy SMILES
Affinity DataIC50: 265nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527559(US11186588, Example 14)copy SMILES
Affinity DataIC50: 276nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527618(US11186588, Example 103 | US11186588, Example 99)copy SMILES
Affinity DataIC50: 289nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527556(US11186588, Example 11)copy SMILES
Affinity DataIC50: 291nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527584(US11186588, Example 48)copy SMILES
Affinity DataIC50: 297nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
TargetNuclear factor NF-kappa-B p105 subunit(Homo sapiens (Human))TBA
LigandPNGBDBM527615(Synthesis of | US11186588, Example 90)copy SMILES
Affinity DataIC50: 298nMAssay Description:A549/NF-κB-luc cells (available from Panomics, Cat No. LR0051) were prepared at 375,000 cells/mL in the culture medium. The 375,000 cells/mL A54...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21R6TQ4US Patent
Displayed 1 to 50 (of 94 total ) | Next | Last >>
Jump to: